SOPHARMA AD - Notification from Bissera Lazarova in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. BLazarova_Sopharma_EN_10092025.pdfNotification from Bissera Lazarova in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 148 / 2025

Date of issue: 2025-09-10

Short name of the issuer

SOPHARMA AD

Subject

Notification from Bissera Lazarova in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Notification from Bissera Lazarova in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

Annexes

File Description

BLazarova_Sopharma_EN_10092025.pdfBLazarova_Sopharma_EN_10092025.pdf Notification from Bissera Lazarova in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2025-09-10 Ognian Ivanov Donev Executive Director